PL3525799T3 - Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka - Google Patents

Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka

Info

Publication number
PL3525799T3
PL3525799T3 PL17817868T PL17817868T PL3525799T3 PL 3525799 T3 PL3525799 T3 PL 3525799T3 PL 17817868 T PL17817868 T PL 17817868T PL 17817868 T PL17817868 T PL 17817868T PL 3525799 T3 PL3525799 T3 PL 3525799T3
Authority
PL
Poland
Prior art keywords
restoring
establishing
ocular surface
homeostasis
preserving
Prior art date
Application number
PL17817868T
Other languages
English (en)
Polish (pl)
Inventor
Wolfgang Georg Konrad Muller-Lierheim
Gysbert-Botho Van Setten
Original Assignee
i.com medical GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60766004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3525799(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by i.com medical GmbH filed Critical i.com medical GmbH
Publication of PL3525799T3 publication Critical patent/PL3525799T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL17817868T 2016-10-14 2017-10-02 Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka PL3525799T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662408559P 2016-10-14 2016-10-14
US201762516911P 2017-06-08 2017-06-08
EP17817868.7A EP3525799B1 (en) 2016-10-14 2017-10-02 Method for establishing, restoring, and preserving homeostasis of the ocular surface
PCT/IB2017/001364 WO2018069763A1 (en) 2016-10-14 2017-10-02 Method for establishing, restoring, and preserving homeostasis of the ocular surface

Publications (1)

Publication Number Publication Date
PL3525799T3 true PL3525799T3 (pl) 2022-05-16

Family

ID=60766004

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17817868T PL3525799T3 (pl) 2016-10-14 2017-10-02 Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka

Country Status (8)

Country Link
US (1) US20190240251A1 (cg-RX-API-DMAC10.html)
EP (2) EP3525799B1 (cg-RX-API-DMAC10.html)
JP (3) JP2019532105A (cg-RX-API-DMAC10.html)
KR (1) KR20190068575A (cg-RX-API-DMAC10.html)
ES (1) ES2909998T3 (cg-RX-API-DMAC10.html)
HU (1) HUE058672T2 (cg-RX-API-DMAC10.html)
PL (1) PL3525799T3 (cg-RX-API-DMAC10.html)
WO (1) WO2018069763A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2909998T3 (es) * 2016-10-14 2022-05-11 I Com Medical Gmbh Método para establecer, restablecer y preservar la homeostasis de la superficie ocular
US12303527B2 (en) 2018-04-18 2025-05-20 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
EP3852725A4 (en) * 2018-09-20 2022-08-03 The Hong Kong University of Science and Technology EYE DROP COMPOSITIONS
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
JP2023530286A (ja) * 2020-06-12 2023-07-14 アイ．コム メディカル ゲーエムベーハー 角膜神経損傷又は喪失の治療に使用する高分子量ヒアルロン酸
ES3008008T3 (en) * 2020-06-21 2025-03-21 I Com Medical Gmbh Use of high molecular weight hyaluronic acid as ocular transporting vehicle
EP4536189A4 (en) * 2022-06-08 2026-07-29 The Schepens Eye Research Inst Inc METHODS OF TREATING DRY EYE DISEASE
EP4591860A1 (en) * 2024-01-23 2025-07-30 FB Vision S.p.A. Ophthalmic pharmaceutical composition for the prevention and treatment of dry eye syndrome

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
JP3050898B2 (ja) * 1990-07-06 2000-06-12 千寿製薬株式会社 水性医薬製剤
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
PT1142566E (pt) * 2000-04-07 2004-02-27 Medidom Lab Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
JP2002193815A (ja) * 2000-12-25 2002-07-10 Ophtecs Corp 眼手術用角膜乾燥防止点眼剤
US6528464B1 (en) * 2001-08-17 2003-03-04 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
JP3779200B2 (ja) * 2001-11-28 2006-05-24 電気化学工業株式会社 ヒアルロン酸及び／又はその塩の水溶液の安定化組成物
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
EP1455750B1 (en) * 2001-12-21 2006-02-08 Alcon, Inc. Viscoelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulphate
US20060094643A1 (en) * 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
DE10360425A1 (de) 2003-12-19 2005-07-28 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
US20080306022A1 (en) * 2005-10-12 2008-12-11 Kenji Miyamoto Agent for Applying to Mucosa and Method for the Production Thereof
JP2007145765A (ja) * 2005-11-29 2007-06-14 Menicon Co Ltd 眼科手術用組成物
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
EP2187900B1 (en) * 2007-08-16 2016-11-09 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
CA2724052A1 (en) * 2008-05-15 2009-11-19 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
JP5595206B2 (ja) * 2009-09-30 2014-09-24 ロート製薬株式会社 眼科用液体組成物
US8283463B2 (en) * 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
HRP20230776T1 (hr) * 2010-07-29 2023-10-27 Buzzard Pharmaceuticals AB Himerni antagonisti receptora il-1 tipa i
CA2810481C (en) * 2010-09-10 2018-06-19 Santen Pharmaceutical Co., Ltd. Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
SG11201703572SA (en) * 2014-12-02 2017-05-30 Regeneron Pharma Animal model for dry eye and methods of use of such animals
TW202114648A (zh) * 2015-03-06 2021-04-16 日商參天製藥股份有限公司 眼科用組成物
US20170014339A1 (en) 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
ES2909998T3 (es) 2016-10-14 2022-05-11 I Com Medical Gmbh Método para establecer, restablecer y preservar la homeostasis de la superficie ocular
US12303527B2 (en) * 2018-04-18 2025-05-20 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
US12268706B2 (en) * 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain

Also Published As

Publication number Publication date
EP3525799B1 (en) 2022-01-26
EP3871682A1 (en) 2021-09-01
WO2018069763A1 (en) 2018-04-19
US20190240251A1 (en) 2019-08-08
JP2025029084A (ja) 2025-03-05
ES2909998T3 (es) 2022-05-11
KR20190068575A (ko) 2019-06-18
HUE058672T2 (hu) 2022-09-28
EP3525799A1 (en) 2019-08-21
JP2022153583A (ja) 2022-10-12
JP2019532105A (ja) 2019-11-07

Similar Documents

Publication Publication Date Title
IL266596A (en) Causes, uses and methods of treating synovialitis
IL254533A0 (en) Systems and methods for heart valve therapy
IL256501B (en) Causes, uses and methods of treating synuclein pathology
IL269490B (en) Surface treatment methods and compositions therefor
EP3151797A4 (en) Methods and devices for treating the skin
PL3648595T3 (pl) Sposób konserwacji pyłku
SG11201801790UA (en) Polishing liquid, polishing liquid set, and substrate polishing method
EP3252124A4 (en) Surface treatment agent
SG11202001013YA (en) Polishing liquid, polishing liquid set and polishing method
EP3119532A4 (en) Treated article and method of making the same
EP3122408A4 (en) Pressurizing masks, systems and methods
SG10202003053VA (en) Deactivation wipe kit and method of forming and using the same
HUE058672T2 (hu) Eljárás a szemfelület homeosztázisának megállapítására, helyreállítására és megõrzésére
EP3484515A4 (en) METHOD FOR TREATING FIBROSE
EP3375568A4 (en) Surface treatment device and surface treatment method
PT3430883T (pt) Aparelho de varejar, particularmente para varejar oliveiras e semelhantes
IL271728A (en) Materials, uses and treatment methods
SG11202002314WA (en) Polishing solution, polishing solution set, and polishing method
EP3551027B8 (en) Machine for the drying of dishes or the like and method for the drying of dishes or the like with said machine.
EP3219787A4 (en) Agent for preserving biological component, and method for recovering biological component
EP3176149A4 (en) Method for improving preservation stability of 2,2-difluoroacetoaldehyde
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
TWI561676B (zh) 水性金屬表面處理劑及使用其之金屬表面處理方法
EP3423063A4 (en) COMPOSITIONS AND METHODS FOR TREATING SEARCH OR SUBSTANCE ABUSE MISTAKES
PT3585985T (pt) Método de conservação